
Research and development in cancer, infection, and inflammation to improve therapeutics.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: January 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
GlaxoSmithKline France
A
Research and development of pharmaceuticals in respiratory, immunological, inflammatory diseases, oncology, HIV, and infectious diseases.
cri - centre de recherche sur l'inflammation
B
Research in the pathophysiology of inflammatory and fibrotic diseases, oncogenic inflammation and tumor development, and immunology, cell signaling, and dynamics.
Fondation pour la Recherche Médicale
B
Funding medical research projects in various fields such as cancer, cardiovascular diseases, infectious diseases, neurological and psychiatric diseases, and rare diseases.
Initiatives identified among leaders
Réduction des émissions de gaz à effet de serre
“GlaxoSmithKline France a pour objectif de réduire ...” - GlaxoSmithKline FranceMise en place d'un dispositif de signalement et de traitement des actes de violences
“Mise en place d'un dispositif de signalement et de...” - cri - centre de recherche sur l'inflammationÉtudes en vie réelle pour comprendre les besoins des patients
“Études en vie réelle pour comprendre les besoins d...” - GlaxoSmithKline France62% of similar organizations communicate on CSR issues
+472 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports